The JCVI agreed in June 2014 that it would be appropriate for some JCVI subcommittees to receive presentations from manufacturers to inform them on specific topics relevant to the work of the committee. The decision to engage with manufacturers will be taken on a case by case basis in response to the particular information needs of individual sub-committees. The engagement of vaccine manufacturers with subcommittees is a move designed to ensure a sub-committee has an opportunity to critically assess the most up to date (and often unpublished) information about vaccines being considered.
The purpose of this paper is to set out the process for this engagement to ensure transparency and that it does not damage the reputation of the JCVI, or allow manufacturers to influence, or be seen to influence the decision making of the sub-committee or the JCVI.
- Functioning
- Europe
- United Kingdom
- vaccine manufacturers
